Moelis (NYSE:MC) Stock

MOELIS & CO - CLASS A

Moelis

Moelis & Co is an independent investment bank that provides strategic and financial advice to a diverse client base, including corporations, financial sponsors, governments, and sovereign wealth funds. The company assists its clients in achieving their strategic goals by offering comprehensive, globally integrated financial advisory services across all industry sectors. It also advises clients on their critical decisions, including mergers and acquisitions, recapitalizations and restructurings, capital markets transactions, and other corporate finance matters. it generates revenue from advisory transactions. The firm derives a majority of its revenue from the United States followed by Europe and the rest of the World.

Moelis & Co

Merit Circle - United States Dollar

Mountain & Co I Acquisition Corp Ordinary Shares - Class A

Mountain & Co I Acquisition Corp

Mountain & Co I Acquisition Corp Units (1 Ord Class A & 1/2 War)

Mountain & Co I Acquisition Corp Warrants - (04/11/2026)

MONTEREY CAP ACQUISITION CORP CL A

MONTEREY CAP ACQUISITION CORP RT

MONTEREY CAP ACQUISITION CORP UNIT 1 CL A & 1 RT & 1 WT

MONTEREY CAP ACQUISITION CORP WT EXP

Mountain Crest Acquisition Corp IV

MOUNTAIN CREST ACQUISITION CORP IV RT

Mountain Crest Acquisition Corp IV Units (1 Ordinary Shares& 1 Rights)

MOUNTAIN CREST ACQ V by Mountain Crest Acquisition Corp. V

Mountain Crest Acquisition Corp V

MOUNTAIN CREST ACQUISITION CORP V RT

Mountain Crest Acquisition Corp V Units (1 Ordinary Shares, 1 Rights)

MCAP Inc

Mercari Inc

Mcashchain

MacroAsia Corp

Metropolitan Bank Holding Corp. Common Stock

Metropolitan Bank Holding Corp

MCDEX Token

Macatawa Bank Corp. Com

MOUNTAIN COMM BANCORP INC by Mountain Commerce Bancorp Inc.

Mountain Commerce Bancorp Inc

MADISON COUNTY FINCL INC by Madison County Financial, Inc.

Madison County Financial Inc

MERHAV-CERMC & BLDG MTRLS by MERHAV-CERAMIC & BUILDING MATERIALS CENTER LTD.

Hamat Group Ltd

MICHIGAN COMMUTY BNCRP by Michigan Community Bancorp Ltd.

McBride PLC

MetroCity Bankshares, Inc. - Common Stock

MetroCity Bankshares Inc

MCCHIP RESOURCES INC by McChip Resources, Inc.

McChip Resources Inc

Mestek Inc

MCCOY GLOBAL INC ORD by McCoy Global, Inc.

McCoy Global Inc

MCX Technologies Corp

McDonald's Corp

KMA Holding Inc

McDermott International Ltd Warrants - Class B (30/06/2027)

McDermott International Ltd

McDermott International Ltd Ordinary Shares

MCDERMOTT INTL LTD by McDermott International LTD.

MACDONALD MINES EXPL LTD by MacDonald Mines Exploration Ltd.

JPMorgan Fundamental Data Science Mid Core ETF

McDermott International Ltd Warrants - Class A (30/06/2027)

MILLENNIUM CELL INC by Millennium Cell, Inc.

Millennium Cell Inc

MONARCH CEMENT CO by Monarch Cement Co. (The)

Monarch Cement Co

MULTICELL TECHS INC by MultiCell Technologies, Inc.

MultiCell Technologies Inc

MCF Energy Ltd

MasterCraft Boat Holdings, Inc. - Common Stock

MasterCraft Boat Holdings Inc

Matthews International Funds Matthews China Active ETF

MATCHAAH HOLDING INC by Matchaah Holdings, Inc.

Matchaah Holdings Inc

MECHANICS BK RICHMOND CAL by Mechanics Bank of Richmond (CA)

Mechanics Bank

MACMAHON HOLDINGS LTD ORD by MacMahon Holdings Ltd.

Macmahon Holdings Ltd

iShares MSCI China ETF

MARUICHI STEEL TUBE LTD by Maruichi Steel Tube Ltd.

Maruichi Steel Tube Ltd

McHenry Bancorp Inc Com (New)

MULTICHOICE GROUP SP/ADR by MultiChoice Group Limited

MultiChoice Group Ltd

Microchip Technology Incorporated - Common Stock

Microchip Technology Inc

Microchip Technology Incorporated - Depositary Shares Each Representing a 1/20th Interest in a Share of 7.50% Series A Mandatory Convertible Preferred Stock

Matthews China Discovery Active ETF

M CASH INTEGRASI TBK ORD by M Cash Integrasi Tbk PT

MAUCH CHUNK TR FINCL CORP by Mauch Chunk Trust Financial Corp.

Mauch Chunk Trust Financial Corp

MGM CHINA HOLDINGS ORD by MGM China Holdings, Ltd.

MGM China Holdings Ltd

MGM CHINA HLDGS UNSP/ADR by MGM China Holdings, Ltd.

Marchex Inc

Barings Corporate Investors

MERCIA ASSET MGMT PLC by Mercia Asset Mgmt Plc

Mercia Asset Management PLC

MULTICORP INTL INC by Multicorp International, Inc.

MultiCorp International Inc

MACAU CAP INVSTS INC NEW by Macau Capital Investments, Inc.

Macau Capital Investments Inc

MCI Onehealth Technologies Inc Ordinary Shares - Class A (Sub Voting)

MCJ Co Ltd

McKesson Corp

MALLINCKRODT PB LTD CO by Mallinckrodt plc.

Jade Leader Corp

MORSES CLUB PLC by MORSES CLUB PLC

MCLOUD TECHNOLOGIES INC by MCLOUD TECHNOLOGIES CORP.

mCloud Technologies Corp

Medicale Corp

MCLOUD TECHS CORP 9 PFD A by MCLOUD TECHNOLOGIES CORP.

mCloud Technologies Corp Warrants (29/11/2026)

XAI Madison Equity Premium Income Fund Common Shares

XAI Madison Equity Premium Income Fund

Macnica Holdings Inc

MUCINNO HOLDING INC by Mucinno Holding, Inc.

Mucinno Holding Inc

MILLENNIUM & CPTHRNE HTLS by Millennium & Copthorne Hotels New Zealand Ltd.

Millennium & Copthorne Hotels New Zealand Ltd

Moodys Corp

MCO - United States Dollar

Moss Carbon Credit - United States Dollar

MARIJUANA CO OF AMER INC by Marijuana Company of America, Inc.

Marijuana Company of America Inc

MULTICHOICE GROUP LIMITED by MultiChoice Group Limited

MICROMOBILITY.COM INC A by Micromobility.com Inc.

Micromobility com Inc

Micromobility com Inc Warrants (28/10/2024)

MT CARMEL PUBLIC UTIL CO by Mt. Carmel Public Utility Co.

Mount Carmel Public Utility Co

Midland Capital Holdings Corp Com

MOCHIDA PHARM CO LTD by Mochida Pharmaceutical Co., Ltd.

Mochida Pharmaceutical Co Ltd

MACQUARIE GRP LTD by Macquarie Group, Ltd.

Macquarie Group Ltd

MFS Charter Income Trust

MCRAE INDUS INC A by McRae Industries, Inc.

McRae Industries Inc

MCRAE INDUS INC B by McRae Industries, Inc.

Seres Therapeutics Inc

MICROPORT CRDFLW MD U/ADR by MICROPORT CARDIOFLOW MEDTECH CORP.

MicroPort CardioFlow Medtech Corp

METALS CREEK RES by Metals Creek Resources Corp.

Metals Creek Resources Corp

Monarch Casino & Resort, Inc. - Common Stock

Monarch Casino & Resort Inc

MICRO-MECHANICS LTD ORD by Micro-Mechanics Ltd.

Micro-Mechanics (Holdings) Ltd

Micropolis Holding Company Ordinary Shares

Micropolis Holding Co

MICROPORT SCIENTIFIC CORP by Microport Scientific Corp.

MicroPort Scientific Corp

Ratings for Moelis (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MC#NYSE">MC</a>) were provided by 7 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">5</td>
<td align="right">2</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have set 12-month price targets for Moelis, revealing an average target of $58.14, a high estimate of $75.00, and a low estimate of $42.00. This current average has decreased by 16.09% from the previous average price target of $69.29. 
<img src="https://www.benzinga.com/files/images/story/2025/1747346457_0.png" alt="price target chart" />
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
In examining recent analyst actions, we gain insights into how financial experts perceive Moelis. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>James Yaro</td>
<td>Goldman Sachs</td>
<td>Raises</td>
<td>Neutral</td>
<td>$63.00</td>
<td>$56.00</td>
</tr>
<tr>
<td>Kenneth Worthington</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$52.00</td>
<td>$55.00</td>
</tr>
<tr>
<td>Michael Brown</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$50.00</td>
<td>$55.00</td>
</tr>
<tr>
<td>Michael Brown</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$55.00</td>
<td>$63.00</td>
</tr>
<tr>
<td>Ryan Kenny</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$42.00</td>
<td>$70.00</td>
</tr>
<tr>
<td>James Yaro</td>
<td>Goldman Sachs</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$75.00</td>
<td>$86.00</td>
</tr>
<tr>
<td>Ryan Kenny</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$70.00</td>
<td>$100.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Moelis. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Moelis compared to the broader market.</li>
<li>Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of Moelis's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Moelis's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/MC/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Moelis analyst ratings.</a>
<h2>About Moelis</h2>
Moelis &amp; Co is an independent investment bank that provides strategic and financial advice to a diverse client base, including corporations, financial sponsors, governments, and sovereign wealth funds. The company assists its clients in achieving their strategic goals by offering comprehensive, globally integrated financial advisory services across all industry sectors. It also advises clients on their critical decisions, including mergers and acquisitions, recapitalizations and restructurings, capital markets transactions, and other corporate finance matters. it generates revenue from advisory transactions. The firm derives a majority of its revenue from the United States followed by Europe and the rest of the World.
<h3>Moelis's Economic Impact: An Analysis</h3>
Market Capitalization Perspectives: The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.
Revenue Growth: Moelis's remarkable performance in 3M is evident. As of 31 March, 2025, the company achieved an impressive revenue growth rate of 40.97%. This signifies a substantial increase in the company's top-line earnings. When compared to others in the Financials sector, the company excelled with a growth rate higher than the average among peers.
Net Margin: Moelis's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of 16.4%, the company may encounter challenges in effective cost control.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 10.86%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): Moelis's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 3.89% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.45.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings

Forecasting The Future: 7 Analyst Projections For Moelis

Goldman Sachs analyst James Yaro maintains Moelis (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MC#NYSE">MC</a>) with a Neutral and raises the price target from $56 to $63.

News

Price Target

Goldman Sachs Maintains Neutral on Moelis, Raises Price Target to $63

WIIM

ARCC

BRDG

COIN

CRBG

GSIW

HLNE

HOOD

IBKR

Janus Henderson Group plc Ordinary Shares

LPLA

LPRO

OBDC

OXBR

PIPR

PRAA

PowerShares Exchange Traded Fund Trust Dynamic Mid Cap Value Portfolio

QFIN

SHF Holdings, Inc. - Class A Common Stock

SHFS

SOFI

STEP

UPST

VCTR

Shares of companies within the broader financial sector are higher after the US and China agreed to a temporary reduction in most tariffs on each other's goods.

JP Morgan analyst Kenneth Worthington maintains Moelis (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MC#NYSE">MC</a>) with a Neutral and lowers the price target from $55 to $52.

JP Morgan Maintains Neutral on Moelis, Lowers Price Target to $52

JMP Securities analyst Devin Ryan reiterates Moelis (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MC#NYSE">MC</a>) from Market Perform to Market Perform.

Reiteration

JMP Securities Reiterates Market Perform on Moelisto Market Perform

Throughout the last three months, 9 analysts have evaluated Moelis (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MC#NYSE">MC</a>), offering a diverse set of opinions from bullish to bearish.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">5</td>
<td align="right">2</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $72.67, a high estimate of $100.00, and a low estimate of $42.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 8.01%. 
<img src="https://www.benzinga.com/files/images/story/2025/1745503230_0.png" alt="price target chart" />
<h2>Analyzing Analyst Ratings: A Detailed Breakdown</h2>
The standing of Moelis among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;--------------------&#x7C;-----------------------&#x7C;---------------&#x7C;---------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;Michael Brown &#x7C;Wells Fargo &#x7C;Lowers &#x7C;Equal-Weight &#x7C; $50.00&#x7C;$55.00 &#x7C; 
&#x7C;Michael Brown &#x7C;Wells Fargo &#x7C;Lowers &#x7C;Equal-Weight &#x7C; $55.00&#x7C;$63.00 &#x7C; 
&#x7C;Ryan Kenny &#x7C;Morgan Stanley &#x7C;Lowers &#x7C;Underweight &#x7C; $42.00&#x7C;$70.00 &#x7C; 
&#x7C;James Yaro &#x7C;Goldman Sachs &#x7C;Lowers &#x7C;Neutral &#x7C; $75.00&#x7C;$86.00 &#x7C; 
&#x7C;Ryan Kenny &#x7C;Morgan Stanley &#x7C;Lowers &#x7C;Underweight &#x7C; $70.00&#x7C;$100.00 &#x7C; 
&#x7C;James Yaro &#x7C;Goldman Sachs &#x7C;Raises &#x7C;Neutral &#x7C; $87.00&#x7C;$79.00 &#x7C; 
&#x7C;Aidan Hall &#x7C;Keefe, Bruyette &amp; Woods&#x7C;Raises &#x7C;Outperform &#x7C; $92.00&#x7C;$86.00 &#x7C; 
&#x7C;Michael Brown &#x7C;Wells Fargo &#x7C;Raises &#x7C;Equal-Weight &#x7C; $83.00&#x7C;$77.00 &#x7C; 
&#x7C;Ryan Kenny &#x7C;Morgan Stanley &#x7C;Raises &#x7C;Overweight &#x7C; $100.00&#x7C;$95.00 &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Moelis. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Moelis compared to the broader market.</li>
<li>Price Targets: Analysts navigate through adjustments in price targets, providing estimates for Moelis's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
To gain a panoramic view of Moelis's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/MC/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Moelis analyst ratings.</a>
<h2>Get to Know Moelis Better</h2>
Moelis &amp; Co is an independent investment bank that provides strategic and financial advice to a diverse client base, including corporations, financial sponsors, governments, and sovereign wealth funds. The company assists its clients in achieving their strategic goals by offering comprehensive, globally integrated financial advisory services across all industry sectors. It also advises clients on their critical decisions, including mergers and acquisitions, recapitalizations and restructurings, capital markets transactions, and other corporate finance matters. it generates revenue from advisory transactions. The firm derives a majority of its revenue from the United States followed by Europe and the rest of the World.
<h3>Unraveling the Financial Story of Moelis</h3>
Market Capitalization Analysis: The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.
Positive Revenue Trend: Examining Moelis's financials over 3M reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 104.17% as of 31 December, 2024, showcasing a substantial increase in top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Financials sector.
Net Margin: Moelis's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 20.38% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): Moelis's ROE stands out, surpassing industry averages. With an impressive ROE of 22.1%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): Moelis's ROA stands out, surpassing industry averages. With an impressive ROA of 7.06%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: Moelis's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.51.
<h2>What Are Analyst Ratings?</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Expert Outlook: Moelis Through The Eyes Of 9 Analysts

Wells Fargo analyst Michael Brown maintains Moelis (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MC#NYSE">MC</a>) with a Equal-Weight and lowers the price target from $55 to $50.

Wells Fargo Maintains Equal-Weight on Moelis, Lowers Price Target to $50

Moelis (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MC#NYSE">MC</a>) reported quarterly earnings of $0.64 per share which beat the analyst consensus estimate of $0.59 by 8.47 percent. This is a 190.91 percent increase over earnings of $0.22 per share from the same period last year. The company reported quarterly sales of $306.59 million which missed the analyst consensus estimate of $314.56 million by 2.53 percent. This is a 40.97 percent increase over sales of $217.49 million the same period last year.

Comments

Moelis

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL